Nawel is a biochemist, having undertaken her PhD with Dr. A. De Agostini (Department of Pathology and Immunology) at the Faculty of Medicine, University of Geneva. She investigated the role of aHSPG post biosynthetic modification and its implication on endometrial cancer invasion and angiogenesis (2015-2020). She is currently doing her postdoc working on targeting BRCA mutated ovarian cancer resistant to PARP inhibitors. Nawel has been important for the development of organoid cell lines
Jonathan obtained a Bachelor’s degree from Swansea University Medical School in the UK. During his BSc, Jonathan had the chance to contribute to reasearch investigating epigenetic mechanisms in ovarian cancer with the use of Bromodomain inhibitors. In 2020, Jonathan joined the Labidi-Galy lab for a 5 month internship, investigating the impact of menopause on breast cancer in BRCA1 carriers. During this time, he worked alongside Lou Romanens PhD to optimise the microdissection of fresh frozen tumour samples and helped further develop Multiplex IHC machine learning. In 2021, Jonathan joined the laboratory again, this time acting as laboratory manager.
Visiting Ph.D. Student
Zeinab is visiting Ph.D. student from the University of Tehran. She is currently doing her Ph.D. internship in the Labidi-Galy lab working on a study with the aim of deciphering and better understanding the role of the tumor microenvironment in endometriosis and endometriosis-associated of ovarian cancer. She is currently analysing tissue microarrays using multiplex immunohistochemistry.